OTC · Financial Statements
BioHarvest Sciences Inc. (CNVCF) Financial Statements
$6.30
OTC: CNVCF
Market Cap $109.16M
Overview Financials Dividend BioHarvest Sciences Inc. most recently reported annual revenue of $13.0M, a net loss of $13.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $0 $0 $2.0M $5.0M $13.0M Operating Profit $-2.0M $-6.0M $-8.0M $-11.0M $-10.0M Net Profit $-5.0M $-7.0M $-10.0M $-11.0M $-13.0M EPS $-1.80 $-0.68 $-0.79 $-0.86 $-0.93 Op Margin -1059.6% -1557.1% -403.9% -193.0% -78.7%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $2.0M $5.0M $10.0M $9.0M $15.0M Total Liabilities $29.0M $8.0M $7.0M $15.0M $30.0M Cash $1.0M $2.0M $4.0M $2.0M $5.0M Borrowings $24.0M $3.0M $2.0M $11.0M $22.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-2.0M $-4.0M $-7.0M $-9.0M $-9.0M Investing Cash Flow $0 $0 $-3.0M $-3.0M $-3.0M Financing Cash Flow $2.0M $0 $4.0M $1.0M $0 Net Cash Flow $0 $1.0M $2.0M $-2.0M $4.0M Free Cash Flow $-2.0M $-4.0M $-8.0M $-10.0M $-10.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.36 EV / EBITDA -15.81 FCF Yield -9.72% Quick Ratio 0.29 Interest Coverage -1.48 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .